Literature DB >> 22752395

Thrombotic microangiopathy and acute kidney injury following vivax malaria.

Aditi Sinha1, Geetika Singh, Abdus Sami Bhat, Sarita Mohapatra, Ashima Gulati, Pankaj Hari, J C Samantaray, Amit Kumar Dinda, Sanjay Kumar Agarwal, Arvind Bagga.   

Abstract

BACKGROUND: Infection with Plasmodium vivax, a common human parasite, is occasionally recognized to cause severe organ dysfunction similar to P. falciparum infection. Acute kidney injury (AKI) in malaria is attributed to acute tubular necrosis; thrombotic microangiopathy is not described.
METHODS: This observational study includes patients referred to a tertiary care center in North India during June to September 2011 with severe AKI, anemia, and thrombocytopenia following vivax malaria. Renal biopsies were processed by light, immunofluorescence, and electron microscopy.
RESULTS: Nine patients (including 5 children) had persistent AKI with thrombocytopenia and variable anemia following the diagnosis of malaria. Based on peripheral smear, eight patients were diagnosed with vivax malaria and had received antimalarial therapy prior to referral; a laboratory diagnosis of P. vivax infection was made for one patient at this center. Renal histology in all cases showed features of thrombotic microangiopathy, including fibrin thrombi, subendothelial widening, and mesangiolysis, along with variable tubulointerstitial nephritis and acute tubular or cortical necrosis. Ultrastructural examination confirmed endothelial injury and subendothelial widening. All patients required hemodialysis, and six were dialysis dependent at four weeks. Delayed presentation to the hospital (P = 0.019), hemolysis on peripheral smear (P = 0.083), and prolonged oligoanuria (P = 0.036) were associated with dialysis dependence.
CONCLUSION: The association of anemia, thrombocytopenia, and renal histological evidence of thrombotic microangiopathy with vivax malaria is novel, and suggests the presence of severe endothelial injury. Further studies are necessary to confirm the association and examine the factors associated with its occurrence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752395     DOI: 10.1007/s10157-012-0656-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  [May Plasmodium falciparum induce a hemolytic uremic syndrome?].

Authors:  L Adonis-koffy
Journal:  Arch Pediatr       Date:  2004-01       Impact factor: 1.180

2.  Acute renal failure in falciparum malaria--increasing prevalence in some areas of India--a need for awareness.

Authors:  J Prakash; A Gupta; O Kumar; S B Rout; V Malhotra; P K Srivastava
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

Review 3.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

4.  Plasmodium vivax malaria presenting as hemolytic--uremic syndrome.

Authors:  J Sharma; K Bharadawa; K Shah; S Dave
Journal:  Indian Pediatr       Date:  1993-03       Impact factor: 1.411

5.  On the cytoadhesion of Plasmodium vivax-infected erythrocytes.

Authors:  Bruna O Carvalho; Stefanie C P Lopes; Paulo A Nogueira; Patricia P Orlandi; Daniel Y Bargieri; Yara C Blanco; Ronei Mamoni; Juliana A Leite; Mauricio M Rodrigues; Irene S Soares; Tatiane R Oliveira; Gerhard Wunderlich; Marcus V G Lacerda; Hernando A del Portillo; Maria O G Araújo; Bruce Russell; Rossarin Suwanarusk; Georges Snounou; Laurent Rénia; Fabio T M Costa
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria.

Authors:  Quirijn de Mast; Evelyn Groot; Puji B Asih; Din Syafruddin; Marije Oosting; Silvie Sebastian; Bart Ferwerda; Mihai G Netea; Philip G de Groot; Andre J A M van der Ven; Rob Fijnheer
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

7.  Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria.

Authors:  M W Weber; K Böker; R D Horstmann; J H Ehrich
Journal:  Trop Med Parasitol       Date:  1991-06

8.  Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.

Authors:  Dhanpat K Kochar; Ashish Das; Sanjay K Kochar; Vishal Saxena; Parmendra Sirohi; Shilpi Garg; Abhishek Kochar; Mahesh P Khatri; Vikas Gupta
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

9.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods.

Authors:  Richard E Cibulskis; Maru Aregawi; Ryan Williams; Mac Otten; Christopher Dye
Journal:  PLoS Med       Date:  2011-12-20       Impact factor: 11.069

View more
  14 in total

1.  Postrenal transplant Plasmodium vivax malaria: neglected and not benign.

Authors:  Vivek B Kute; Aruna V Vanikar; Pankaj R Shah; Jigar D Shrimali; Manoj R Gumber; Himanshu V Patel; Pranjal R Modi; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

Review 2.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Acute Kidney Injury in Children with Plasmodium falciparum Malaria: Determinants for Mortality.

Authors:  Rajniti Prasad; Om P Mishra
Journal:  Perit Dial Int       Date:  2015-10-01       Impact factor: 1.756

4.  Malaria-induced splenic infarction.

Authors:  Jeong-Hwan Hwang; Chang-Seop Lee
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

5.  Hemolytic uremic syndrome in a developing country: Consensus guidelines.

Authors:  Arvind Bagga; Priyanka Khandelwal; Kirtisudha Mishra; Ranjeet Thergaonkar; Anil Vasudevan; Jyoti Sharma; Saroj Kumar Patnaik; Aditi Sinha; Sidharth Sethi; Pankaj Hari; Marie-Agnes Dragon-Durey
Journal:  Pediatr Nephrol       Date:  2019-04-15       Impact factor: 3.714

6.  Etiology and Outcomes of Thrombotic Microangiopathies.

Authors:  Guillaume Bayer; Florent von Tokarski; Benjamin Thoreau; Adeline Bauvois; Christelle Barbet; Sylvie Cloarec; Elodie Mérieau; Sébastien Lachot; Denis Garot; Louis Bernard; Emmanuel Gyan; Franck Perrotin; Claire Pouplard; François Maillot; Philippe Gatault; Bénédicte Sautenet; Emmanuel Rusch; Matthias Buchler; Cécile Vigneau; Fadi Fakhouri; Jean-Michel Halimi
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-12       Impact factor: 8.237

7.  Malaria and acute kidney injury.

Authors:  Denver D Brown; Sonia Solomon; Daniele Lerner; Marcela Del Rio
Journal:  Pediatr Nephrol       Date:  2019-01-31       Impact factor: 3.714

8.  Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Authors:  Deborah J Stearns-Kurosawa; Sun-Young Oh; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh; James Papin; Joel Henderson; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2013-02-10       Impact factor: 4.307

9.  Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria.

Authors:  Bridget E Barber; Timothy William; Matthew J Grigg; Uma Parameswaran; Kim A Piera; Ric N Price; Tsin W Yeo; Nicholas M Anstey
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

10.  Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange.

Authors:  V S Keskar; T E Jamale; N K Hase
Journal:  Indian J Nephrol       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.